- Home
- RPRX vs ZM Comparison
RPRX vs ZM Comparison
Compare RPRX & ZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | ZM |
|---|---|---|
| Founded | 1996 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5B | 21.8B |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RPRX | ZM |
|---|---|---|
| Price | $47.29 | $82.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 22 |
| Target Price | $47.75 | ★ $94.14 |
| AVG Volume (30 Days) | 2.9M | ★ 3.0M |
| Earning Date | 05-07-2026 | 05-20-2026 |
| Dividend Yield | ★ 1.94% | N/A |
| EPS Growth | N/A | ★ 92.52 |
| EPS | 1.78 | ★ 6.18 |
| Revenue | $2,378,193,000.00 | ★ $4,868,769,000.00 |
| Revenue This Year | $38.30 | $7.30 |
| Revenue Next Year | $4.80 | $3.96 |
| P/E Ratio | $27.29 | ★ $13.33 |
| Revenue Growth | ★ 5.06 | 4.36 |
| 52 Week Low | $30.04 | $65.63 |
| 52 Week High | $49.06 | $97.58 |
Technical Indicators
Market Signals| Indicator | RPRX | ZM |
|---|---|---|
| Relative Strength Index (RSI) | 58.36 | 58.47 |
| Support Level | $44.84 | $81.62 |
| Resistance Level | $47.86 | $84.98 |
| Average True Range (ATR) | 0.92 | 2.35 |
| MACD | 0.11 | 1.08 |
| Stochastic Oscillator | 61.20 | 94.76 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About ZM Zoom Video Communications Inc.
Zoom Communications provides a video-first communications platform that connects people through frictionless video, voice, chat, and content sharing. The company's cloud-native platform enables video experiences and connects users across various devices and locations in a single meeting. Zoom has launched a variety of communications-related solutions, including Zoom Phone and Zoom Contact Center. The firm was founded in 2011 and serves companies of all sizes from all industries around the world.